Skip to main content
. 2022 Jan 12;14(2):368. doi: 10.3390/cancers14020368
ADT Androgen deprivation therapy
AS Active surveillance
CSS Cancer specific survival
CT Chemo-therapy
DRE Digital rectal examination
EAU European association of urology
EBRT External beam radio therapy
FU Follow-up
GS Gleason score
LFT Lost to follow-up
LUTS Lower urinary tract symptoms
mpMRI multi-parametric magnetic resonance imaging
OS Overall survival
PCa Prostate cancer
PI-RADS Prostate Imaging Reporting & Data System
PSA Prostate specific antigen
PSAD PSA-Density
PVol Prostate volume
RFS recurrence-free survival
RP Radical prostatectomy
TRUS Transrectal ultrasound
TURP Transurethral resection of the prostate
TZ Transitional zone
WW Watchful waiting